The Canadian nuclear reactor that satisfies more than half of demand of molybdenum-99 for medical nuclear imaging services in North America will not return to service until the first quarter of 2010.
The Canadian nuclear reactor that satisfies more than half of demand of molybdenum-99 for medical nuclear imaging services in North America will not return to service until the first quarter of 2010.
Atomic Energy Canada Limited announced Wednesday that it was rolling back the estimated startup date for the National Research Universal reactor at Chalk River, ON. The reactor was shut down May 14 after a heavy-water leak penetrating its vessel wall was discovered. AECL initially estimated repairs would be completed in late 2009.
The shutdown triggered a widespread shortage of Mo-99, the precursor isotope necessary for the production of technetium-99m, a radioisotope used in a majority of nuclear medicine procedures. Most nuclear medicine departments in the U.S. and Canada were affected. The situation worsened in June when the High Flux Reactor at Petten, the Netherlands, another important source of Mo-99 production, was shut down for planned routine maintenance.
Dr. Jean-Luc Urbain, chairman of nuclear medicine at the University of Western Ontario in London, told Diagnostic Imaging during an Aug. 4 interview that his department was receiving only 40% of its usual Mo-99 consignment. As with many facilities in Canada and the U.S., his clinic had delayed noncritical imaging procedures and shifted to thallium-201 for nuclear cardiology and FDG PET for cancer diagnosis and staging.
AECL rolled back its reactor startup date to Q1 2010 after a nondestructive survey of the containment vessel identified nine sites of corrosive wall-thinning requiring repair.
Safety-related problems at the NRU reactor have been the cause of two extended medical isotope shortages since 2007. The current incident triggered calls in the U.S. for Congress to approve funding to reestablish a domestic source of Mo-99. The last domestic provider ceased operations in 1989.
What a New Meta-Analysis Reveals About Fractional Flow Reserve Assessment with Computed Tomography
May 13th 2024While acknowledging variable accuracy overall with CT-derived fractional flow reserve (FFR-CT) values, researchers found that the accuracy rate increased to 90 percent for FFR-CT values greater > 0.90 and < 0.49.
Study Finds High Concordance Between AI and Radiologists for Cervical Spine Fractures on CT
May 6th 2024Researchers found a 98.3 percent concordance between attending radiology reports and AI assessments for possible cervical spine fractures on CT, according to new research presented at the 2024 ARRS Annual Meeting.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can a CT-Based Radiomics Model Bolster Detection of Malignant Thyroid Nodules?
May 3rd 2024A computed tomography (CT)-based radiomics model that includes 28 radiomic features showed significantly higher accuracy, sensitivity, and specificity than conventional CT in differentiating benign and malignant thyroid nodules, according to newly published research.
Study Reveals Benefits of Photon-Counting CT for Assessing Acute Pulmonary Embolism
April 23rd 2024In comparison to energy-integrating detector CT for the workup of suspected acute pulmonary embolism, the use of photon-counting detector CT reduced radiation dosing by 48 percent, according to newly published research.